Skip to content

Incidence Of Chronic Pain after SARS-CoV-2

Incidence Of Chronic Pain after SARS-CoV-2 - INOPAC

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00024473
Enrollment
200
Registered
2021-06-22
Start date
2021-09-17
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

J12.8 G63.0 F43.1 G93.3

Interventions

Group 1: Alle Patients with a severe case of COVID-19 who were admitted to hospital and required oxygen.

Sponsors

Universitätsklinikum Tübingen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - PCR-positive case of SARS-CoV-2 - Admitted to hospital - Requiring oxygen 1 l/min or more

Exclusion criteria

Exclusion criteria: - Age <18 years - Not admitted to hospital - No oxygen administration

Design outcomes

Primary

MeasureTime frame
Incidence of chronic pain after severe cases of COVID-19

Secondary

MeasureTime frame
- Incidence of chronic pain after COVID-19 with vs. without admittance to ICU - Incidence of PTSB after COVID-19 (total, with vs. without admittance to ICU) - Incidence of fatigue after COVID-19 (total, with vs. without admittance to ICU)

Countries

Germany

Contacts

Public ContactMoritz Sabrow

Klinik für Anästhesiologie und Intensivmedizin

schmerzambulanz@med.uni-tuebingen.de+49/7071/2985535

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026